1-3 of 3
Max M. van Noesel, MD PhD
Close
Sort by
Journal Articles

Poor Survival of CD34 Positive and CD13/33 Positive Patients in Pediatric T-Cell Acute Lymphoblastic Leukemia Is Not Explained by Expression of Multidrug Resistance Genes.

Martine van Grotel, MSc, Max M. van Noesel, MD,PhD, M.M. Van Den Heuvel, MD,PhD, Rob Pieters, MD,PhD, Jules P.P. Meijerink, PhD
Journal: Blood
Blood (2007) 110 (11): 4219.
https://doi.org/10.1182/blood.V110.11.4219.4219
Published: 2007
Journal Articles

Prognostic Significance of Molecular-Cytogenetic Abnormalities in Pediatric T-ALL Is Not Explained by Immunophenotypic Differences.

Martine van Grotel, MSc, Anton W. Langerak, PhD, H. Berna Beverloo, PhD, Jessica G.C.A.M. Buijs-Gladdines, Nicole B. Burger, Max M. van Noesel, MD PhD, Rob Pieters, MD PhD, Jules P.P. Meijerink, PhD
Journal: Blood
Blood (2007) 110 (11): 4220.
https://doi.org/10.1182/blood.V110.11.4220.4220
Published: 2007
Journal Articles

CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Martine van Grotel, MSc, Jules P.P. Meijerink, PhD, Max M. van Noesel, MD, PhD, H. Berna Beverloo, PhD, Anton W. Langerak, PhD, Tim S. Poulsen, PhD, Elisabeth R. van Wering, MD, PhD, E. Gritta Janka-Schaub, MD, PhD, Rob Pieters, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3279.
https://doi.org/10.1182/blood.V106.11.3279.3279
Published: 2005